Patent · US Active

Compounds useful as antagonists of CCR2

US8067457B2 · kind B2 · utility

0Cited by
29References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 26, 2006
Grant dateNov 29, 2011
Priority date
Expiry dateOct 26, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.